Related Experiment Video
Updated: May 30, 2026

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
Published on: May 24, 2016
[Advances of treatment for Duchenne muscular dystrophy with exon skipping]
1Department of Neurology, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510080, P. R. China.
Abstract:
Duchenne muscular dystrophy (DMD) is a lethal muscular disorder caused by mutations in the dystrophin gene for which no mutation targeted therapy has been available so far. However, a new method named exon-skipping mediated by antisense oligonucleotides has considerable potential for DMD therapy. In this review, the principle, basic research and clinical research of exon-skipping are mainly summarized.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Gene Therapy
Gene Therapy
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Huntington Disease l: Introduction

